Probabilities for symptom relief obtained with treatments under the 'status quo' scenario in which non-prescription H2RA is not available for heartburn treatment (OTC figures for non-prescription availability probabilities are in parenthesis):
Symptom relief with antacids:0.68 (0.68);
Over-the counter famotidine: NA (0.74);
Watchful waiting (placebo): 0.63; (0.63):
Prescription H2RA: 0.75 (0.75);
Prescription Proton Pump Inhibitor (PPI): 0.80 (0.80).
No confidence intervals were stated.